Atypical posterior cortical atrophy: a diagnostic and treatment dilemma.
Williamson
Peter
P
Schulich School of Medicine and Dentistry, University of Western Ontario, University Campus-LHSC, 339 Windermere Rd, London, Canada N6A 5A5.
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001284:Atrophy; D002552:Cerebral Ventricles / Q000473:pathology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004292:Dominance, Cerebral / Q000502:physiology*; D005260:Female; D006179:Gyrus Cinguli / Q000098:blood supply / Q000473:pathology; D006212:Hallucinations / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D020961:Lewy Body Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009483:Neuropsychological Tests; D009778:Occipital Lobe / Q000098:blood supply / Q000473:pathology*; D010296:Parietal Lobe / Q000098:blood supply / Q000473:pathology*; D012039:Regional Blood Flow / Q000502:physiology; D013702:Temporal Lobe / Q000098:blood supply / Q000473:pathology; D015899:Tomography, Emission-Computed, Single-Photon
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors